ArticleFrontiers in cell and developmental biology2021

METTL3-Mediated N6-Methyladenosine Modification Is Involved in the Dysregulation of NRIP1 Expression in Down Syndrome.

Weili Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.